ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
35.91
0.06%
US Tech 100
18,240.00
0.24%
S&P 500
5,321.41
0.25%
US Dollar vs CAD
1.36397
0.12%
Bitcoin
70,188.32
-1.77%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Annexon Inc (ANNX)

  7. Annexon Inc (ANNX) News

ANNX

Annexon (ANNX)

Annexon Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ANNX
DateTimeSourceHeadlineSymbolCompany
05/13/20243:10PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ANNXAnnexon Inc
05/13/20243:05PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ANNXAnnexon Inc
04/16/20248:00AMGlobeNewswire Inc.Turnstone Biologics Appoints William Waddill to its Board of DirectorsNASDAQ:ANNXAnnexon Inc
02/21/20243:32PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANNXAnnexon Inc
02/21/20243:32PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANNXAnnexon Inc
02/21/20243:31PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANNXAnnexon Inc
02/20/20242:15PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ANNXAnnexon Inc
02/20/20242:12PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ANNXAnnexon Inc
02/14/20247:46PMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:ANNXAnnexon Inc
02/14/20246:59PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANNXAnnexon Inc
02/14/20246:56PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANNXAnnexon Inc
02/14/20246:52PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANNXAnnexon Inc
02/14/20242:45PMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:ANNXAnnexon Inc
02/13/20246:23PMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:ANNXAnnexon Inc
02/13/20245:57PMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:ANNXAnnexon Inc
02/12/20243:24PMEdgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:ANNXAnnexon Inc
02/12/20242:45PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ANNXAnnexon Inc
02/12/20242:41PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ANNXAnnexon Inc
02/12/20242:39PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ANNXAnnexon Inc
01/23/20244:00PMEdgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:ANNXAnnexon Inc
01/23/20243:58PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANNXAnnexon Inc
01/08/20243:09PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ANNXAnnexon Inc
01/07/20247:00PMGlobeNewswire Inc.Annexon Outlines 2024 Priorities with Late-Stage Clinical Milestones Across Upstream Complement Portfolio for Autoimmune, Ophthalmic and Neurodegenerative DiseasesNASDAQ:ANNXAnnexon Inc
12/29/20233:12PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANNXAnnexon Inc
12/27/20233:50PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ANNXAnnexon Inc
12/27/20235:30AMGlobeNewswire Inc.Annexon Biosciences to Present at the 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:ANNXAnnexon Inc
12/22/20234:28PMEdgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:ANNXAnnexon Inc
12/21/20233:09PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ANNXAnnexon Inc
12/21/20233:05PMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:ANNXAnnexon Inc
12/20/20234:27PMGlobeNewswire Inc.Annexon Announces Pricing of $125.0 Million Underwritten Public Offering of Common StockNASDAQ:ANNXAnnexon Inc
 Showing the most relevant articles for your search:NASDAQ:ANNX

Your Recent History

USOTC
IBGR
Nexus Energy Services (PK)
USOTC
QEDN
QED Connect (PK)
USOTC
WNFT
Worldwide NFT (PK)
USOTC
SRMX
Saddle Ranch Media (PK)
USOTC
ECSL
Ecare Solutions (PK)
USOTC
RONN
Ronn Motor (PK)
USOTC
CBIA
Canopus Biopharma (PK)
USOTC
DPLS
DarkPulse (PK)
USOTC
VXIT
Virexit Technologies (PK)
USOTC
CGAC
Code Green Apparel (PK)
USOTC
WDLF
Decentral Life (PK)
USOTC
BMXI
Brookmount Explorations (PK)
NASDAQ
LWLG
Lightwave Logic
USOTC
GDVM
Global Developments (PK)
USOTC
ERHE
ERHC Energy (CE)
USOTC
GGEI
Green Giant (PK)
Delayed Upgrade Clock
ADVFN Logo

Canada
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved